PBS updates

Lexam 10 (Escitalopram)

escitalopram 10 mg tablet, 28 · ORAL · PBS code 14519E

RESTRICTED

• • First listed on the PBS: 2024-09-01.
• • Repeats: 2.
• • PBS program: GE.

Eligibility criteria for subsidised access

The following is the government's own wording from the PBS Schedule, shown unchanged.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Moderate to severe generalised anxiety disorder (GAD)

The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient; AND

The condition must be defined by Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-V) criteria; AND

Patient must not have responded to non-pharmacological therapy; AND

Patient must be one for whom a GP Mental Health Care Plan, as described under items 2715 or 2717 of the Medicare Benefits Schedule, has been prepared.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Moderate to severe generalised anxiety disorder (GAD)

The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient; AND

The condition must be defined by Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-V) criteria; AND

Patient must not have responded to non-pharmacological therapy; AND

Patient must have been assessed by a psychiatrist.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Moderate to severe social anxiety disorder (social phobia, SAD)

The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient; AND

The condition must be defined by Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-V) criteria; AND

Patient must not have responded to non-pharmacological therapy; AND

Patient must be one for whom a GP Mental Health Care Plan, as described under items 2715 or 2717 of the Medicare Benefits Schedule, has been prepared.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Moderate to severe social anxiety disorder (social phobia, SAD)

The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient; AND

The condition must be defined by Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-V) criteria; AND

Patient must not have responded to non-pharmacological therapy; AND

Patient must have been assessed by a psychiatrist.

Not medical advice. Voxsanity republishes public PBS data in plain English. PBS listing status and criteria can change; always confirm current subsidised availability with your doctor or pharmacist.

Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.